A Single-arm Phase II Clinical Study of the Efficacy and Safety of Camrelizumab Combined With GEMOX for Unresectable GBCs

This study is testing whether a combination of an immunotherapy drug (camrelizumab) and chemotherapy (gemcitabine and oxaliplatin) is safe and effective for people with gallbladder cancer that cannot be removed by surgery. **You may be eligible if...** - You are between 18 and 75 years old - You have been diagnosed with gallbladder cancer that cannot be surgically removed - You have never had chemotherapy or immunotherapy before - You are in reasonably good overall health (able to carry out light activities) - Your liver, kidneys, and blood counts are within acceptable ranges **You may NOT be eligible if...** - You have had another type of cancer (with some exceptions like treated skin cancer) - You have uncontrolled high blood pressure - You have severe heart, lung, or kidney problems - You are pregnant or breastfeeding - You have active HIV, hepatitis B, or tuberculosis - You have had gemcitabine-based chemo or a PD-1/PD-L1 immunotherapy drug in the past 6 months Talk to your doctor to see if this trial is right for you.